SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025066
Filing Date
2020-05-13
Accepted
2020-05-13 16:16:41
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20200331.htm 10-Q 1354810
2 EX-31.1 apvo-ex311_7.htm EX-31.1 19293
3 EX-31.2 apvo-ex312_9.htm EX-31.2 19467
4 EX-32.1 apvo-ex321_8.htm EX-32.1 10282
5 EX-32.2 apvo-ex322_6.htm EX-32.2 10389
  Complete submission text file 0001564590-20-025066.txt   4854591

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT apvo-20200331.xml EX-101.INS 841261
7 XBRL TAXONOMY EXTENSION SCHEMA apvo-20200331.xsd EX-101.SCH 50337
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20200331_cal.xml EX-101.CAL 43610
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20200331_def.xml EX-101.DEF 135023
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20200331_lab.xml EX-101.LAB 358376
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20200331_pre.xml EX-101.PRE 270601
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 20873366
SIC: 2834 Pharmaceutical Preparations